Alcon acquires STAAR Surgical
Alcon agreed to acquire STAAR Surgical. Reported deal value: $1.5B. Status: Pending. Sector: Vision Correction. Target headquarters context: Lake Forest, California, United States.
This page summarizes publicly available information about the transaction as of 2026-01-07. Figures and status may change as filings and press coverage update.
STAAR Surgical has announced that it will terminate the proposed acquisition by Alcon based on preliminary estimates by STAAR proxy solicitor showing that the company did not receive the necessary stockholder votes to approve the merger agreement with Alcon at the Special Meeting of Stockholders held on January 6, 2026.1,2 This decision follows a lengthy back-and-forth in 2025 between STAAR / Alcon and Broadwood Partners, the largest private stockholder in STAAR , owning 30.2%, and the biggest proponent against the merger
Deal timeline
This transaction is classified in Vision Correction with a reported deal value of $1.5B. Figures and status may change as sources update.